789TiPHALO 109-301: Phase III, randomized, double-blind, placebo-controlled study of pegvorhyaluronidase alfa (PEGPH20) + nab-paclitaxel/gemcitabine (AG) in patients with previously untreated hyaluronan (HA)-high stage IV pancreatic ductal adenocarcinoma (PDA)
Van Cutsem, E, Corrie, P G, Ducreux, M P, Sigal, D, Sahai, V, Oh, D-Y, Bullock, A, Bang, Y-J, Baron, A D, Hendifar, A, Li, C-P, Philip, P, Reni, M, Zalupski, M, Zheng, L, Berman, C, Chondros, D, TempeVolume:
29
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdy282.172
Date:
October, 2018
File:
PDF, 76 KB
english, 2018
File converter
More search results
More benefits 
